Clindamycin does work for strep throat and is recommended as an alternative antibiotic when penicillin or amoxicillin can’t be used. The Infectious Diseases Society of America includes clindamycin on its list of approved options for patients with penicillin allergies. It’s also particularly effective for people dealing with recurring strep infections that haven’t responded to standard treatment.
Why Clindamycin Is a Second-Line Option
Penicillin and amoxicillin remain the first choices for strep throat because Group A Strep bacteria have zero resistance to them. Clindamycin works through a different mechanism: it latches onto a key part of the bacterial cell’s protein-making machinery, stopping the bacteria from building the proteins they need to survive and multiply. This also changes the bacteria’s outer surface, making it harder for them to stick to your throat cells and easier for your immune system to destroy them.
One notable advantage of clindamycin is that it suppresses toxin production. Strep bacteria release toxins that drive inflammation and pain, so reducing toxin output can help beyond simply killing the bacteria. The drug also concentrates well inside immune cells, which boosts the body’s natural ability to clear the infection. Still, it’s reserved as an alternative rather than a go-to because it carries a higher risk of certain side effects and faces growing resistance among strep strains.
How Effective It Is Compared to Penicillin
In a head-to-head study of children with strep throat, clindamycin cleared the bacteria from the throat in 90% of cases, compared to 82% for penicillin. That’s a comparable success rate, and it confirms clindamycin reliably eliminates the infection when taken as directed.
Where clindamycin really stands out is in recurrent strep throat. A study of 53 patients who had already failed a standard course of penicillin found striking results: when re-treated with penicillin, 15 out of 22 patients tested positive for strep again within three months. In the clindamycin group, only 3 out of 26 had a recurrence, and all three were new infections from a different strain rather than a relapse. Researchers concluded that clindamycin could protect against recurrence for at least three months and might serve as an alternative to tonsillectomy for people stuck in a cycle of repeated infections.
The 10-Day Course
The CDC recommends a 10-day course of oral clindamycin for strep throat. The standard dose is taken three times daily. Most people start feeling noticeably better within two to three days of starting any effective antibiotic for strep, though you need to finish the entire 10-day course even after symptoms improve. Stopping early increases the risk of the bacteria surviving and the infection returning.
Three-times-daily dosing can be more inconvenient than amoxicillin’s typical twice-daily schedule. If you’re picking up your child from school or managing a busy routine, it helps to set reminders so doses stay evenly spaced throughout the day.
Resistance Is a Growing Concern
This is the most important caveat. CDC surveillance data shows that roughly 1 in 3 invasive Group A Strep infections are now caused by bacteria resistant to clindamycin. That’s a significant number. While invasive infections (like bloodstream infections) aren’t the same as a straightforward sore throat, the resistance patterns overlap. If your doctor prescribes clindamycin for strep, they may order a sensitivity test from your throat culture to confirm the specific strain will respond to the drug.
By contrast, Group A Strep has no known resistance to penicillin or amoxicillin. This is the core reason those drugs remain the default choice whenever a patient can tolerate them.
Side Effects to Expect
The most common side effects of clindamycin are digestive: nausea, vomiting, and diarrhea. Some people notice a metallic or unpleasant taste in the mouth. Joint pain and vaginal yeast infections can also occur, since the antibiotic disrupts normal bacterial balance throughout the body.
The more serious risk is a gut infection caused by a bacterium called C. diff, which can flourish when antibiotics wipe out the normal bacteria in your intestines. A large case-control study found that clindamycin carried the highest risk of community-associated C. diff infection of any antibiotic studied, with an odds ratio above 25. In practical terms, that means the risk is meaningfully elevated compared to most other antibiotics. Symptoms of C. diff include watery diarrhea (often three or more times a day), fever, and abdominal cramping. If you develop persistent or worsening diarrhea during or after your clindamycin course, that warrants prompt medical attention.
For a standard 10-day course treating a straightforward sore throat, C. diff remains uncommon in otherwise healthy people. But the elevated risk is a real reason doctors don’t reach for clindamycin first.
When Clindamycin Makes the Most Sense
Clindamycin fits best in a few specific situations. If you have a true penicillin allergy, it’s one of your recommended alternatives. If you’ve gone through a full course of penicillin or amoxicillin and the strep infection came back, clindamycin’s ability to penetrate deeper into throat tissue and eliminate bacteria hiding inside cells makes it well suited for breaking that cycle. It’s also used when a patient is allergic to both penicillin and the cephalosporin family of antibiotics, which narrows the options further.
For a first episode of strep throat in someone who tolerates penicillin, there’s no advantage to choosing clindamycin. The standard options are cheaper, carry fewer side effects, and face no resistance from the bacteria causing the infection.